Article -> Article Details

Market Overview

The global Neurothrombectomy Devices Market reached a size of USD 733.3 Million in 2024. Forecasts project the market to grow to USD 1,184.4 Million by 2033, exhibiting a CAGR of 5.03% during the 2025-2033 period. Neurothrombectomy devices are used to retrieve or destroy blood clots in cerebral neurovasculature, primarily for rapid recanalization in acute ischemic stroke treatment, thus improving patient outcomes and reducing mortality.

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

Neurothrombectomy Devices Market Key Takeaways

• The global neurothrombectomy devices market size was USD 733.3 Million in 2024, and it is expected to reach USD 1,184.4 Million by 2033, growing at a CAGR of 5.03% during 2025-2033.
• Neurothrombectomy is performed to retrieve or destroy blood clots in cerebral neurovasculature using laser, mechanical, and ultrasound technologies.
• These devices are extensively used in the treatment of acute ischemic stroke (AIS), improving functional outcomes and minimizing mortality.
• Rising cases of AIS, especially among the geriatric population, are driving market expansion.
• Technological advancements and rapid product approvals, such as Medtronic’s Solitaire X and Vesalio’s NeVa, bolster market growth.
• Increasing demand for minimally invasive surgeries and adoption of unhealthy lifestyles also support market growth.

Sample Request Link: https://www.imarcgroup.com/neurothrombectomy-devices-market/requestsample

Market Growth Factors

Acute ischemic stroke (AIS) prevalence increases across the globe, projecting growth for the neurothrombectomy devices market during the forecast period. According to the WHO, stroke is one of the leading causes of dementia and depression in the world because of death of brain cells. As neurothrombectomy devices remove blood clots to redirect blood supply to the brain and reduce mortality rates, the increase in AIS incidence, especially in the senior population, will drive the market.

The market gained fuel from quick technological advances and regulatory approvals. Medtronic PLC launched the Solitaire X revascularization device, its fourth-generation and next-generation model, during April 2019. While the system was outfitted with a new delivery system, it was otherwise unchanged beyond that. In May 2019, Vesalio received CE mark approval for NeVa with DropZone and Smart Marker technology and a distal filter to improve the device's safety and efficacy.

Increasing prevalence of unhealthy lifestyles and rise in demand for minimally intrusive surgical procedures is anticipated to increase the market growth. The rising demand for neurothrombectomy devices can be attributed to advantages such as reduced chances of hemorrhagic complications and faster recanalization. It enables steady growth for the period from 2025 to 2033.

Market Segmentation

By Product:

• Clot Retrievers: Devices designed to physically capture and remove clots from neurovasculature in stroke patients.
• Aspiration/Suction Devices: Tools that use suction mechanisms to remove blood clots from cerebral vessels.
• Vascular Snares: Specialized instruments used to ensnare and extract clots during neurothrombectomy.
• Others: Additional device types utilized in neurothrombectomy procedures serving various treatment needs.

By End Use:

• Hospitals and Clinics: Primary healthcare facilities employing neurothrombectomy devices for treating acute ischemic stroke.
• Ambulatory Surgical Centers: Healthcare centers providing outpatient surgical services including neurothrombectomy treatments.
• Others: Other healthcare settings and institutions utilizing these devices.

By Region:

• North America: Includes the United States and Canada.
• Asia-Pacific: Covers China, Japan, India, South Korea, Australia, Indonesia, and other countries.
• Europe: Comprises Germany, France, United Kingdom, Italy, Spain, Russia, and others.
• Latin America: Brazil, Mexico, and other countries.
• Middle East and Africa

Regional Insights

North America is a dominant region in the neurothrombectomy devices market, supported by advanced healthcare infrastructure, increased awareness, and rising AIS prevalence. The report covers major countries like the United States and Canada. Other prominent regions include Asia-Pacific and Europe, which have substantial demand driven by aging populations and technological adoption.

Recent Developments & News

In April 2019, Medtronic PLC launched its fourth-generation Solitaire X revascularization device designed for acute ischemic stroke treatment featuring an optimized delivery system. In May 2019, Vesalio received CE mark approval for its advanced NeVa neurothrombectomy device, which includes the DropZone and Smart Marker technologies and a distal filter to improve procedural efficiency.

Key Players

• Acandis GmbH
• Shandong Weigao Group Medical Polymer Company Limited
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Koninklijke Philips N.V.
• Medtronic Plc
• Penumbra Inc.
• Phenox GmbH
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Vesalio LLC

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization: https://www.imarcgroup.com/request?type=report&id=3479&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302